Heranova Lifesciences is a Burlington, Massachusetts–based biotech solely focused on women’s health. Led by CEO Dr. Jonathan Y. Zhao and Chief Diagnostic Medical Officer Dr. Farideh Bischoff, the company develops internally built and externally partnered diagnostics, drugs, and devices. It intends to launch a series of non-invasive endometriosis tests and advance two therapeutic programs: a non-hormonal treatment for endometriosis and a non-antibiotic program for bacterial vaginosis. The company has established presences in the United States and Asia. Heranova aims to address unmet needs in women’s healthcare through integrated diagnostics and therapeutic offerings and has raised capital to support those initiatives.

Total raised

$14M

Funding rounds

1

Latest round

Seed

Latest activity

Jan 2024